Search liu.se

The aim of our research is to identify, validate and implement genetic markers or other biomarkers to predict drug metabolism or drug effects.

Our aim is to maintain a common, logical nomenclature system for thiopurine methyltransferase (TPMT) alleles in humans.

Our research is within the field of Drug research and Onco-pharmacology. Our aim is to identify drugs with new mechanisms of action, and try to develop drug candidates for clinical use.

Some patients experience life-threatening side effects during cancer treatment. Researchers at LiU have developed a model that can predict which patients have a high probability of side effects.

LiU scientists are working intensely to develop two different analysis methods for the immune response that follows infection by the SARS-CoV-2 virus. One of the tests is now being used by the medical care services in Region Östergötland.